Determination of the age of onset to the osteoporosis screening program and frequency of osteoporosis: Düzce University Training and Research Hospital sampling

Yıl 2017, Cilt: 9 Sayı: 1, 30 - 34, 23.03.2017

Yılmaz Mehmet Alper Başbuğ Aşkı Ellibeş Kaya Mete Çağlar Attila Özkara Mehmet Ali Sungur Safinaz Ataoğlu

https://doi.org/10.18521/ktd.286409

Cited By: 1

Öz

Aim: In our study, we aimed to determine the age of onset to the osteoporosis screening program and frequency of osteoporosis in the who admitted Düzce University Training and Research Hospital

Material and Methods: Between the dates 01.01.2015 and 31.12.2015, 400 women between the ages of 40 and 70, who applied to Düzce University Training and Research Hospital, Departments of Physical Therapy and Rehabilitation, Gynecology and Obstetrics, and Orthopedics, and had got their femoral neck and L1-L4 anterior vertebra BMD (Bone Mineral Density) measured with DXA method, were included in our research. With the FRAX trial questionnaire have conducted to determine major osteoporotic fracture risk, patient data were recorded via asking questions to patients.

Statistics: In the statistical analysis, Independent Samples T-test was evaluated for group comparison of continuous variables, Pearson's chi-square test was used for the analysis of relations between categorical variables, and Pearson's correlation analysis was used to review the relations between continuous variables.

Results: In our study, we determined the mean age of osteoporosis group as 60.6 while the frequency was demonstrated as 11.8%.

Conclusion: For our region, we determined the age of onset for osteoporosis screening as 60 for women without a major osteoporotic fracture risk factor.

Anahtar Kelimeler

osteoporosis, bone mineral density, DXA, dual X-ray absorbsiyometri

Osteoporoz Sıklığı ve Tarama Programı Başlangıç Yaşının Belirlenmesi: Düzce Üniversitesi Araştırma ve Uygulama Hastanesi Örneklemi

Öz

Amaç: Yaptığımız bu çalışmada Düzce Üniversitesi Araştırma ve Uygulama Hastanesine başvuran kadınlarda osteoporoz sıklığını ve osteoporoz tarama başlangıç yaşını belirlemeyi amaçladık.

Materyal ve Metod: Düzce Üniversitesi Araştırma ve Uygulama Hastanesi fizik tedavi ve rehabilitasyon, kadın hastalıkları ve doğum ve ortopedi polikliniklerine 01.01.2015-31.12.2015 tarihleri arasında başvurarak DXA metoduyla femur boynu ve L1-L4 anterior vertebra KMY’ları ( Kemik mineral yoğunluğu) ölçülen 40 ile 70 yaş arasındaki 400 kadın çalışmaya dahil edildi. Majör osteoporotik kırık riskini belirlemek amacıyla FRAX çalışması anket soruları kadınlara sorularak bilgiler kaydedildi.

İstatistik: İstatistiksel analiz; gruplar arası Sürekli değişkenler Independent Samples T-test, kategorik değişkenler ise Pearson's chi-square test kullanılarak yapıldı. Sürekli değişkenler arasındaki ilişkiyi belirlemek için Pearson's korelasyon analizi kullanıldı.

Bulgular: Çalışmamıza katılan kadınlar arasında osteoporoz sıklığını 11.8% ve osteoporoz grubunun yaş ortalamasını 60.6 olarak bulduk.

Sonuç: Hastanemizin hizmet verdiği bölgede majör osteoporotik kırık risk faktörü bulunmayan kadınlarda osteoporoz taraması 60 yaşında başlamalıdır.

Anahtar Kelimeler

Osteoporoz, kemik mineral yoğunluğu, DEXA, dual X-ray absorbsiyometri

Kaynakça

• 1- Cosman F, de Beur S J, LeBoff M S, Lewiecki EM, Tanner B, Randall S et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 2014; 25:2359–2381.
• 2- Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporosis Int. 1992 Nov;2(6):285-9.
• 3- Papaioannou P, MorinS, Cheung AM, Atkinson S, Brown JP, Feldman S et al. for the Scientific Advisory Council of Osteoporosis Canada. 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. CMAJ 2010 ;182(17).
• 4- Eryavuz M. Osteoporozun tanımı, sınıflandırması ve epidemiyolojik çalışmalar. Gökçe YK (Ed). Fiziksel Tıp ve Rehabilitasyon 2002: 1-10
• 5- WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and management of osteoporosis: report of a WHO scientific group. Internet Communication. 2007
• 6- Nelson B. Watts, John P. Bilezikian, Pauline M. Camacho, Susan L. Greenspan, Steven T. Harris, Stephen F. Hodgson et al. Amerıcan assocıatıon of clınıcal endocrınologısts medıcal guıdelınes for clınıcal practıce for the dıagnosıs and treatment of postmenopausal osteoporosıs. Endocr Pract. 2010 Nov-Dec; 16(Suppl 3): 1–37.
• 7- Hajime Orimo, Toshitaka Nakamura, Takayuki Hosoi, Masayuki Iki, Kazuhiro Uenishi, Naoto Endo. Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary. Arch Osteoporos. 2012 Dec; 7(1-2): 3–20.
• 8- Türkiye Endokrinoloji ve Metabolizma Derneği. Osteoporoz ve Metabolik Kemik Hastalıkları Tanı ve Tedavi Kılavuzu. 11. Baskı. Ankara, 2016; 11-14.
• 9- NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 2001;285:785-95.
• 10- Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis Int 2014:doi 10.1007/s00198-014-2794-2.
• 11- National Osteoporosis Foundation.Clinician’s guide to prevention and treatment of Osteoporosis, Washington D.C.2014.
• 12- AACE Medical Guidelines for clinical practice fort he diagnosis and treatment of postmenopausal osteoporosis. Endocrine Practice 2010: 16(Suppl 3): 1-37.
• 13- National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.
• 14- Schousboe JT, Vokes T, Broy SB, Ferrar L, McKiernan F, Roux C, Binkley N. Vertebral fracture assessment: the 2007 ISCD official positions. J Clin Densitom 2008;11:92-108
• 15- ACOG Practice Bulletin N. 129. Osteoporosis. Committee on Practice Bulletins-Gynecology, The American College of Obstetricians and Gynecologists. Obstet Gynecol. 2012 Sep;120(3):718-34.
• 16- 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada) Dr. Jacques P. Brown,at al. To revise and expand the 1996 Osteoporosis Society of Canada clinical practice guidelines for the management of osteoporosis. CMAJ November 12, 2002 vol. 167 no. 10 suppl S1-S34
• 17- The Middle East & Afrıca Regıonal Audit, Epidemiology, costs & burden of osteoporosis in 2011. International Osteoporosis Foundation “IOF” 2011 basımı.. Ş.Tüzün,Ü. Akarırmak. Türkiye verileri: 59-62.
• 18- Arasıl T, Osteoporoz Epidemiyolojisi ve Türkiye Verileri. Türkiye Klinikleri JPM& R. Special Topics 2009;2(1):1-8.
• 19- Lokeer AC,Orwoll ES,Johnson CC. Prevalence of low femoral density in older US adults from NHANCES III. J Bone Mineer Res. 1997;12:1761-1768.